Cargando…
Response to: Amantadine, COVID-19 and Parkinsonism
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IMSS. Published by Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369578/ https://www.ncbi.nlm.nih.gov/pubmed/32723524 http://dx.doi.org/10.1016/j.arcmed.2020.07.002 |
| _version_ | 1783560802423275520 |
|---|---|
| author | Aranda-Abreu, Gonzalo Emiliano |
| author_facet | Aranda-Abreu, Gonzalo Emiliano |
| author_sort | Aranda-Abreu, Gonzalo Emiliano |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7369578 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | IMSS. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73695782020-07-20 Response to: Amantadine, COVID-19 and Parkinsonism Aranda-Abreu, Gonzalo Emiliano Arch Med Res Letters to the Editor IMSS. Published by Elsevier Inc. 2020-10 2020-07-20 /pmc/articles/PMC7369578/ /pubmed/32723524 http://dx.doi.org/10.1016/j.arcmed.2020.07.002 Text en © 2020 IMSS. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letters to the Editor Aranda-Abreu, Gonzalo Emiliano Response to: Amantadine, COVID-19 and Parkinsonism |
| title | Response to: Amantadine, COVID-19 and Parkinsonism |
| title_full | Response to: Amantadine, COVID-19 and Parkinsonism |
| title_fullStr | Response to: Amantadine, COVID-19 and Parkinsonism |
| title_full_unstemmed | Response to: Amantadine, COVID-19 and Parkinsonism |
| title_short | Response to: Amantadine, COVID-19 and Parkinsonism |
| title_sort | response to: amantadine, covid-19 and parkinsonism |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369578/ https://www.ncbi.nlm.nih.gov/pubmed/32723524 http://dx.doi.org/10.1016/j.arcmed.2020.07.002 |
| work_keys_str_mv | AT arandaabreugonzaloemiliano responsetoamantadinecovid19andparkinsonism |